Intelligent bio solutions inc. announces pricing of $4,000,000 underwritten public offering

New york, oct. 02, 2023 (globe newswire) -- intelligent bio solutions inc. (nasdaq: inbs) (the “company”), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced the pricing of an underwritten public offering of units (the “units”) for gross proceeds of approximately $4.0 million.
INBS Ratings Summary
INBS Quant Ranking